首页> 美国卫生研究院文献>The Journal of Experimental Medicine >Sustained Receptor Activation and Hyperproliferation in Response to Granulocyte Colony-stimulating Factor (G-CSF) in Mice with a Severe Congenital Neutropenia/Acute Myeloid Leukemia–derived Mutation in the G-CSF Receptor Gene
【2h】

Sustained Receptor Activation and Hyperproliferation in Response to Granulocyte Colony-stimulating Factor (G-CSF) in Mice with a Severe Congenital Neutropenia/Acute Myeloid Leukemia–derived Mutation in the G-CSF Receptor Gene

机译:G-CSF受体基因严重先天性中性粒细胞减少/急性粒细胞白血病衍生突变的小鼠对粒细胞集落刺激因子(G-CSF)的持续受体激活和过度增殖。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In approximately 20% of cases of severe congenital neutropenia (SCN), mutations are found in the gene encoding the granulocyte colony-stimulating factor receptor (G-CSF–R). These mutations introduce premature stop codons, which result in truncation of 82–98 COOH-terminal amino acids of the receptor. SCN patients who develop secondary myelodysplastic syndrome and acute myeloid leukemia almost invariably acquired a GCSFR mutation, suggesting that this genetic alteration represents a key step in leukemogenesis. Here we show that an equivalent mutation targeted in mice (gcsfr-Δ715) results in the selective expansion of the G-CSF– responsive progenitor (G-CFC) compartment in the bone marrow. In addition, in vivo treatment of gcsfr-Δ715 mice with G-CSF results in increased production of neutrophils leading to a sustained neutrophilia. This hyperproliferative response to G-CSF is accompanied by prolonged activation of signal transducer and activator of transcription (STAT) complexes and extended cell surface expression of mutant receptors due to defective internalization. In view of the continuous G-CSF treatment of SCN patients, these data provide insight into why progenitor cells expressing truncated receptors clonally expand in vivo, and why these cells may be targets for additional genetic events leading to leukemia.
机译:在大约20%的严重先天性中性粒细胞减少症(SCN)病例中,在编码粒细胞集落刺激因子受体(G-CSF–R)的基因中发现了突变。这些突变引入了过早的终止密码子,导致受体的82–98个COOH末端氨基酸被截断。发生继发性骨髓增生异常综合症和急性髓性白血病的SCN患者几乎总是获得GCSFR突变,这表明这种基因改变代表白血病发生的关键步骤。在这里,我们证明了靶向小鼠的等效突变(gcsfr-Δ715)导致了骨髓中G-CSF反应性祖细胞(G-CFC)的选择性扩增。另外,用G-CSF在体内治疗gcsfr-Δ715小鼠导致嗜中性粒细胞产生增加,导致持续的嗜中性粒细胞增多。对G-CSF的过度增殖反应伴随着信号转导子和转录激活子(STAT)复合物的延长激活,以及由于内在缺陷导致突变受体的细胞表面表达延长。鉴于对SCN患者进行连续G-CSF治疗,这些数据提供了深入了解为何表达截短受体的祖细胞在体内克隆扩增,以及为什么这些细胞可能成为导致白血病的其他遗传事件的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号